Antioxidants and Second Messengers of Free Radicals

Total Page:16

File Type:pdf, Size:1020Kb

Antioxidants and Second Messengers of Free Radicals antioxidants Antioxidants and Second Messengers of Free Radicals Edited by Neven Zarkovic Printed Edition of the Special Issue Published in Antioxidants www.mdpi.com/journal/antioxidants Antioxidants and Second Messengers of Free Radicals Antioxidants and Second Messengers of Free Radicals Special Issue Editor Neven Zarkovic MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Neven Zarkovic Rudjer Boskovic Institute Croatia Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Antioxidants (ISSN 2076-3921) from 2018 (available at: https://www.mdpi.com/journal/ antioxidants/special issues/second messengers free radicals) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-533-5 (Pbk) ISBN 978-3-03897-534-2 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Preface to ”Antioxidants and Second Messengers of Free Radicals” ................ ix Neven Zarkovic Antioxidants and Second Messengers of Free Radicals Reprinted from: Antioxidants 2018, 7, 158, doi:10.3390/antiox7110158 ................ 1 Jessica L. H. Walters, Geoffry N. De Iuliis, Brett Nixon and Elizabeth G. Bromfield Oxidative Stress in the Male Germline: A Review of Novel Strategies to Reduce 4-Hydroxynonenal Production Reprinted from: Antioxidants 2018, 7, 132, doi:10.3390/antiox7100132 ................ 5 Giuseppina Barrera, Stefania Pizzimenti, Martina Daga, Chiara Dianzani, Alessia Arcaro, Giovanni Paolo Cetrangolo, Giulio Giordano, Marie Angele Cucci, Maria Graf and Fabrizio Gentile Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders Reprinted from: Antioxidants 2018, 7, 102, doi:10.3390/antiox7080102 ................ 20 Bernd Gesslbauer, David Kuerzl, Niko Valpatic and Valery N. Bochkov Unbiased Identification of Proteins Covalently Modified by Complex Mixtures of Peroxidized Lipids Using a Combination of Electrophoretic Mobility Band Shift with Mass Spectrometry Reprinted from: Antioxidants 2018, 7, 116, doi:10.3390/antiox7090116 ................ 37 Andriy Cherkas and Neven Zarkovic 4-Hydroxynonenal in Redox Homeostasis of Gastrointestinal Mucosa: Implications for the Stomach in Health and Diseases Reprinted from: Antioxidants 2018, 7, 158, doi:10.3390/antiox7110158 ................ 55 Cristina Anna Gallelli, Silvio Calcagnini, Adele Romano, Justyna Barbara Koczwara, Marialuisa de Ceglia, Donatella Dante, Rosanna Villani, Anna Maria Giudetti, Tommaso Cassano and Silvana Gaetani Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues Reprinted from: Antioxidants 2018, 7, 158, doi:10.3390/antiox7110158 ................ 69 Magdalena Timoszuk, Katarzyna Bielawska and Elzbieta˙ Skrzydlewska Evening Primrose (Oenothera biennis) Biological Activity Dependent on Chemical Composition Reprinted from: Antioxidants 2018, 7, 108, doi:10.3390/antiox7080108 ................113 Vera Cesar, Iva Jozi´c, Lidija Begovi´c, Tea Vukovi´c, Selma Mlinari´c, Hrvoje Lepeduˇs, Suzana Borovi´c Sunji´ˇ c and Neven Zarkovi´ˇ c Cell-Type-Specific Modulation of Hydrogen Peroxide Cytotoxicity and 4-Hydroxynonenal Binding to Human Cellular Proteins In Vitro by Antioxidant Aloe vera Extract Reprinted from: Antioxidants 2018, 7, 125, doi:10.3390/antiox7100125 ................124 Agnieszka Gegotek, Anna Jastrzab, Iwona Jarocka-Karpowicz, Marta Muszynska ´ and Elzbieta˙ Skrzydlewska The Effect of Sea Buckthorn (Hippophae rhamnoides L.) Seed Oil on UV-Induced Changes in Lipid Metabolism of Human Skin Cells Reprinted from: Antioxidants 2018, 7, 110, doi:10.3390/antiox7090110 ................138 v Lidija Milkovic, Tea Vukovic, Neven Zarkovic, Franz Tatzber, Egils Bisenieks, Zenta Kalme, Imanta Bruvere, Zaiga Ogle, Janis Poikans, Astrida Velena and Gunars Duburs Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro Reprinted from: Antioxidants 2018, 7, 123, doi:10.3390/antiox7090123 ................159 vi About the Special Issue Editor Neven Zarkovic is a Senior Scientist (tenure) and the Head of the Laboratory for Oxidative Stress (LabOS) at the Rudjer Boskovic Institute in Zagreb, Croatia, where he acted as Associate Director for Science and Counsellor for International Affairs. He obtained his MD in 1984 from the Medical Faculty, Zagreb University. Following his MSc in biology in 1986 and PhD in 1989 he undertook a postdoctoral fellowship as a Lise Meitner awardee at the Institute of Biochemistry of the Karl Franz University of Graz, working mostly with Jorg¨ Schaur and Hermann Esterbauer. His research focuses on oxidative stress and lipid peroxidation and the role of 4-hydroxynonenal (HNE) in the pathophysiology of stress and age-associated disorders. Currently he is coordinating the international offset project on metabolomics in cancer and PTSD patients supported by the Government of Croatia and the Finnish company Patria. He was a founding member of the International HNE-Club (SFRR-I) and now chairs its Steering Committee. Prof. Zarkovic was the proposer and co-ordinator of the European COST Action B35 on lipid peroxidation-associated disorders and was a member of the CMST Domain of COST and of the Board of Governors of EARTO, while he acts now as Study Director of the Interdisciplinary PhD Study Program in Molecular Biosciences and as visiting professor of the Medical University in Bialystok. He is a college professor of economy/management and holds university professorships in biology and in medicine. Professor Zarkovic has (co)authored more than 250 publications, which have been cited more than six thousand times (GS). In 1985, he received the national award for research in pathology, while in 2007 he received the national award for scientific achievements. He is a fellow of the Royal Society of Medicine (RSM, London) and a member of the European Order of St. Georg Knights. vii Preface to ”Antioxidants and Second Messengers of Free Radicals” For decades, chemical species with unpaired electrons known as free radicals, in particular, oxygen free radicals, have been considered to act as enemies of living cells, damaging major bioactive molecules and thus causing degenerative and malignant diseases. Despite this, free radicals are live for very short periods and are highly reactive molecules that also play and important roles in the cellular metabolism. This paradox is further stressed by the fact that some products of the oxidative metabolism of lipids, especially reactive aldehydes, can mimic the bioactivity of free radicals, while living much longer and even acting on long distance. Therefore, there is a lack of general understanding of pathophysiological roles played by reactive aldehydes like malondialdehyde, 4-hydroxynoenal, 4-hydroxyhexenal, acrolein, etc., which are also considered to be “second messengers of free radicals”. Being generated mostly by non-enzymatic lipid peroxidation, they often form bioactive adducts with macromolecules important for the pathophysiology of living cells, even in the absence of severe oxidative stress. This book is based on the Special Issue of Antioxidants comprising original research papers and reviews on complex aspects of reactive aldehydes and their macromolecular adducts (especially with proteins) generated during lipid peroxidation and their interference with natural and synthetic antioxidants in the physiology of cells and in the pathophysiology of various diseases studied by modern bioanalytical methods applied in translational and clinical medicine. Taken together, these scientific papers suggest that understanding the pathophysiology of reactive aldehydes might indeed be crucial to a better understanding of major human diseases, while monitoring their production and controlling them by using efficient antioxidants might help the development of the modern, interdisciplinary life sciences and integrative biomedicine. Neven Zarkovic Special Issue Editor ix antioxidants Editorial Antioxidants and Second Messengers of Free Radicals Neven Zarkovic Laboratory for Oxidative Stress (LabOS), Institute “Rudjer Boskovic”, HR-10000 Zagreb, Croatia; [email protected] Received: 1 November 2018; Accepted: 1 November 2018; Published: 6 November 2018 In the recent years, numerous research on the pathology of oxidative stress has been completed by intense studies on redox signaling implementing various experimental models and clinical trials. Nonetheless, there is still a lack of general understanding of pathophysiological roles played by reactive aldehydes like malondialdehyde, 4-hydroxynonenal, 4-hydroxyhexenal, acrolein, etc., which are considered as “second messengers of free radicals” [1,2]. Mostly being generated by lipid peroxidation, reactive aldehydes often form bioactive adducts with macromolecules
Recommended publications
  • Simultaneous Determination of PUFA-Derived Pro-Resolving Metabolites and Pathway Markers Using Chiral Chromatography and Tandem
    Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chromatography and tandem mass spectrometry Andy Toewe, Laurence Balas, Thierry Durand, Gerd Geisslinger, Nerea Ferreirós To cite this version: Andy Toewe, Laurence Balas, Thierry Durand, Gerd Geisslinger, Nerea Ferreirós. Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chro- matography and tandem mass spectrometry. Analytica Chimica Acta, Elsevier Masson, 2018, 1031, pp.185-194. 10.1016/j.aca.2018.05.020. hal-02405326 HAL Id: hal-02405326 https://hal.archives-ouvertes.fr/hal-02405326 Submitted on 11 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chromatography and tandem mass spectrometry a b b a, c a, * Andy Toewe , Laurence Balas , Thierry Durand , Gerd Geisslinger , Nerea Ferreiros a pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe-University Frankfurt, Germany b Institut des Biomolecules Max Mousseron, IBMM, UMR 5247, University of Montpellier, CNRS, ENSCM, Montepellier, France c Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group TMP, Frankfurt, Germany abstract Lipid mediators play an important role as biological messengers involved in inflammatory processes.
    [Show full text]
  • US EPA Inert (Other) Pesticide Ingredients
    U.S. Environmental Protection Agency Office of Pesticide Programs List of Inert Pesticide Ingredients List 3 - Inerts of unknown toxicity - By Chemical Name UpdatedAugust 2004 Inert Ingredients Ordered Alphabetically by Chemical Name - List 3 Updated August 2004 CAS PREFIX NAME List No. 6798-76-1 Abietic acid, zinc salt 3 14351-66-7 Abietic acids, sodium salts 3 123-86-4 Acetic acid, butyl ester 3 108419-35-8 Acetic acid, C11-14 branched, alkyl ester 3 90438-79-2 Acetic acid, C6-8-branched alkyl esters 3 108419-32-5 Acetic acid, C7-9 branched, alkyl ester C8-rich 3 2016-56-0 Acetic acid, dodecylamine salt 3 110-19-0 Acetic acid, isobutyl ester 3 141-97-9 Acetoacetic acid, ethyl ester 3 93-08-3 2'- Acetonaphthone 3 67-64-1 Acetone 3 828-00-2 6- Acetoxy-2,4-dimethyl-m-dioxane 3 32388-55-9 Acetyl cedrene 3 1506-02-1 6- Acetyl-1,1,2,4,4,7-hexamethyl tetralin 3 21145-77-7 Acetyl-1,1,3,4,4,6-hexamethyltetralin 3 61788-48-5 Acetylated lanolin 3 74-86-2 Acetylene 3 141754-64-5 Acrylic acid, isopropanol telomer, ammonium salt 3 25136-75-8 Acrylic acid, polymer with acrylamide and diallyldimethylam 3 25084-90-6 Acrylic acid, t-butyl ester, polymer with ethylene 3 25036-25-3 Acrylonitrile-methyl methacrylate-vinylidene chloride copoly 3 1406-16-2 Activated ergosterol 3 124-04-9 Adipic acid 3 9010-89-3 Adipic acid, polymer with diethylene glycol 3 9002-18-0 Agar 3 61791-56-8 beta- Alanine, N-(2-carboxyethyl)-, N-tallow alkyl derivs., disodium3 14960-06-6 beta- Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt 3 Alanine, N-coco alkyl derivs.
    [Show full text]
  • Town of Jupiter
    TOWN OF JUPITER DATE: November 19, 2019 TO: Honorable Mayor and Members of Town Council THRU: Matt Benoit, Town Manager FROM: David Brown, Utilities Director MB John R. Sickler, Director of Planning and Zoning SUBJECT: Glyphosate Use Reduction –Resolution to call for a reduction in the use of products containing glyphosate by the Town and its contractors and encouraging a reduction in use by the public HEARING DATES: ETF 11/4/19 PZ #19-4030 TC 11/19/19 Resolution #108-19 EXECUTIVE SUMMARY: Consideration of a resolution recognizing the potential human health and environmental benefits of reducing the use of glyphosate-based herbicides by Town employees and its contractors. Background While glyphosate and formulations such as Roundup have been approved by regulatory bodies worldwide, concerns about their effects on humans and the environment persist, and have grown as the global usage of glyphosate increases. There is a growing belief by some that glyphosate may be carcinogenic. Much of this concern is related to use on food crops and direct exposure via application of the herbicide. In 2015, glyphosate was classified as a probable carcinogen by the International Agency for Research on Cancer, an arm of the World Health Organization (Attachment A). However, this designation was not without controversy (Attachment B) and it is important to note that the U.S. Environmental Protection Agency (EPA) maintains that glyphosate is not likely to be carcinogenic to humans and is not currently banned for use by the U.S. government (pg. 143, Attachment C). In addition, the University of Florida Institute of Food and Agricultural Sciences continues to recommend the use of glyphosate as a weed control tool with the caveat that users of these products must carefully read and follow all label directions (Attachment D).
    [Show full text]
  • Effect of Prostanoids on Human Platelet Function: an Overview
    International Journal of Molecular Sciences Review Effect of Prostanoids on Human Platelet Function: An Overview Steffen Braune, Jan-Heiner Küpper and Friedrich Jung * Institute of Biotechnology, Molecular Cell Biology, Brandenburg University of Technology, 01968 Senftenberg, Germany; steff[email protected] (S.B.); [email protected] (J.-H.K.) * Correspondence: [email protected] Received: 23 October 2020; Accepted: 23 November 2020; Published: 27 November 2020 Abstract: Prostanoids are bioactive lipid mediators and take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. In this review, we focus on their influence on platelets, which are key elements in thrombosis and hemostasis. The function of platelets is influenced by mediators in the blood and the vascular wall. Activated platelets aggregate and release bioactive substances, thereby activating further neighbored platelets, which finally can lead to the formation of thrombi. Prostanoids regulate the function of blood platelets by both activating or inhibiting and so are involved in hemostasis. Each prostanoid has a unique activity profile and, thus, a specific profile of action. This article reviews the effects of the following prostanoids: prostaglandin-D2 (PGD2), prostaglandin-E1, -E2 and E3 (PGE1, PGE2, PGE3), prostaglandin F2α (PGF2α), prostacyclin (PGI2) and thromboxane-A2 (TXA2) on platelet activation and aggregation via their respective receptors. Keywords: prostacyclin; thromboxane; prostaglandin; platelets 1. Introduction Hemostasis is a complex process that requires the interplay of multiple physiological pathways. Cellular and molecular mechanisms interact to stop bleedings of injured blood vessels or to seal denuded sub-endothelium with localized clot formation (Figure1).
    [Show full text]
  • Plant Secondary Metabolites .Pdf
    PLANT SECONDARY METABOLITES W W W . T R C - C A N A D A . C O M +1 (416) 665-9696 www.trc-canada.com 2 Brisbane Road, Toronto [email protected] Plant Secondary Metabolites Product CAS No CAT No Acanthopanax senticosides B 114902-16-8 Please Inquire Acetyl resveratrol 42206-94-0 R150055 Acetylshikonin 24502-78-1 Please Inquire Acronycine 7008-42-6 Please Inquire Acteoside 61276-17-3 V128000 Agrimol B 55576-66-4 Please Inquire Alisol-B-23-acetate 26575-95-1 A535970 Alisol-C-monoacetate 26575-93-9 Please Inquire Alizarin 72-48-0 A536600 Alkannin 517-88-4 Please Inquire Allantoin 97-59-6 A540500 Allantoin-13C2,15N4 1219402-51-3 A540502 Alliin 556-27-4 A543530 Aloe emodin 481-72-1 A575400 Aloe-emodin-d5 1286579-72-3 A575402 Aloenin A 38412-46-3 Please Inquire Aloin A 1415-73-2 A575415 Amentoflavone 1617-53-4 A576420 Amygdalin 29883-15-6 A576840 Andrographolide 5508-58-7 A637475 Angelicin 523-50-2 A637575 Anhydroicaritin 118525-40-9 I163700 Anisodamine 55869-99-3 Please Inquire Anthraquinone 84-65-1 A679245 Anthraquinone-D8 10439-39-1 A679247 Apigenin 520-36-5 A726500 Apigenin-d5 263711-74-6 A726502 Araloside X 344911-90-6 Please Inquire www.trc-canada.com I +1 (416) 665-9696 I [email protected] Plant Secondary Metabolites Arbutin 497-76-7 A766510 Arbutin-13C6 A766512 Arctigenin 7770-78-7 A766580 Arctiin 20362-31-6 A766575 Aristolochic acid I 313-67-7 A771300 Aristolochic acid II 475-80-9 A771305 Aristolochic acid sodium salt 10190-99-5 Please Inquire Aristololactam 13395-02-3 A771200 Artemisinin 63968-64-9 A777500 Artemisinin-d3 176652-07-6
    [Show full text]
  • Timeline of Changes in Appetite During Weight Loss with a Ketogenic Diet
    OPEN International Journal of Obesity (2017) 41, 1224–1231 www.nature.com/ijo ORIGINAL ARTICLE Timeline of changes in appetite during weight loss with a ketogenic diet S Nymo1, SR Coutinho1, J Jørgensen1, JF Rehfeld2, H Truby3, B Kulseng1,4 and C Martins1,4 BACKGROUND/OBJECTIVE: Diet-induced weight loss (WL) leads to increased hunger and reduced fullness feelings, increased ghrelin and reduced satiety peptides concentration (glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK) and peptide YY (PYY)). Ketogenic diets seem to minimise or supress some of these responses. The aim of this study was to determine the timeline over which changes in appetite occur during progressive WL with a ketogenic very-low-energy diet (VLED). SUBJECTS/METHODS: Thirty-one sedentary adults (18 men), with obesity (body mass index: 37 ± 4.5 kg m − 2) underwent 8 weeks (wks) of a VLED followed by 4 wks of weight maintenance. Body weight and composition, subjective feelings of appetite and appetite-related hormones (insulin, active ghrelin (AG), active GLP-1, total PYY and CCK) were measured in fasting and postprandially, at baseline, on day 3 of the diet, 5 and 10% WL, and at wks 9 and 13. Data are shown as mean ± s.d. RESULTS: A significant increase in fasting hunger was observed by day 3 (2 ± 1% WL), (Po0.01), 5% WL (12 ± 8 days) (Po0.05) and wk 13 (17 ± 2% WL) (Po0.05). Increased desire to eat was observed by day 3 (Po0.01) and 5% WL (Po0.05). Postprandial prospective food consumption was significantly reduced at wk 9 (16 ± 2% WL) (Po0.01).
    [Show full text]
  • Review Article SOME PLANTS AS a SOURCE of ACETYL CHOLINESTERASE INHIBITORS: a REVIEW Purabi Deka *, Arun Kumar, Bipin Kumar Nayak, N
    Purabi Deka et al. Int. Res. J. Pharm. 2017, 8 (5) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Review Article SOME PLANTS AS A SOURCE OF ACETYL CHOLINESTERASE INHIBITORS: A REVIEW Purabi Deka *, Arun Kumar, Bipin Kumar Nayak, N. Eloziia Division of Pharmaceutical Sciences, Shri Guru Ram Rai Institute of Technology & Science, Dehradun, India *Corresponding Author Email: [email protected] Article Received on: 27/03/17 Approved for publication: 27/04/17 DOI: 10.7897/2230-8407.08565 ABSTRACT The term dementia derives from the Latin demens (“de” means private, “mens” means mind, intelligence and judgment- “without a mind”). Dementia is a progressive, chronic neurological disorder which destroys brain cells and causes difficulties with memory, behaviour, thinking, calculation, comprehension, language and it is brutal enough to affect work, lifelong hobbies, and social life. Alzheimer’s disease, Parkinson’s disease, Dementia with Lewys Bodies are some common types of dementias. Acetylcholinesterase AChE) Inhibition, the key enzyme which plays a main role in the breakdown of acetylcholine and it is considered as a Positive strategy for the treatment of neurological disorders. Currently many AChE inhibitors namely tacrine, donepezil, rivastigmine, galantamine have been used as first line drug for the treatment of Alzheimer’s disease. They are having several side effects such as gastrointestinal disorder, hepatotoxicity etc, so there is great interest in finding new and better AChE inhibitors from Natural products. Natural products are the remarkable source of Synthetic as well as traditional products. Abundance of plants in nature gives a potential source of AChE inhibitors. The purpose of this article to present a complete literature survey of plants that have been tested for AChE inhibitory activity.
    [Show full text]
  • Thromboxane B2 Production by Fetal and Neonatal Platelets: Effect of Idiopathic Respiratory Distress Syndrome and Birth Asphyxia
    756 KAAPA ET AL. 0031-3998/84/1808-0756$02.00/0 PEOIATRIC RESEARCH Vol. 18, No.8, 1984 Copyright © 1984 International Pediatric Research Foundation, Inc. Printed in U.S.A. Thromboxane B2 Production by Fetal and Neonatal Platelets: Effect of Idiopathic Respiratory Distress Syndrome and Birth Asphyxia 24 PEKKA KAAPA/ ) LASSE VIINIKKA, AND OLAVI YLIKORKALA Departments ofPediatrics and ClinicalChemistry, University ofOulu, Oulu, and Department ofObstetric and Gynecology, University of Helsinki, Helsinki, Finland Summary asphyxia and IRDS, deficient platelet function may be clinically significant, since these conditions are frequently accompanied To study the production of proaggregatory thromboxane A1 by a hemorrhagic tendency (6). (TxA1) by fetal and neonatal platelets, blood specimens were TxA2, the main derivative ofarach idonic acid in the platelets collected from umbilical cords immediately after delivery at term is the most potent endogenous proaggregatory agent which also (n = 22), from newborn infants during the first 10 days of life (n causes vasoconstriction (5). It is produced and released during = 85), from infants between 1 and 3 months of age (n = 14), and platelet aggregation and rapidly converted to its stable metabolite from healthy adults (n = 18). The blood samples were allowed TxB (4,5). Although the significance ofTxA in adults has been to clot spontaneously at +37°C for 60 min, and the concentrations 2 2 exhaustively studied (4), little is known about TxA2 in the human of thromboxane B2 (TxB1), a stable metabolite of TxA1, in the fetus and neonate although birth causes profound adaptations in sera were measured by radioimmunoassay and expressed as 6 platelet vascular functions (3).
    [Show full text]
  • Differences in Thromboxane Production Between Neonatal and Adult Platelets in Response to Arachidonic Acid and Epinephrine
    NEONATAL PLATELET THROMBOXANE FORMATION 823 003 1-3998/84/1809-0823$02.00/0 PEDIATRIC RESEARCH Vol. 18, No. 9, 1984 Copyright O 1984 International Pediatric Research Foundation, Inc. Prinred in (I.S. A. Differences in Thromboxane Production between Neonatal and Adult Platelets in Response to Arachidonic Acid and Epinephrine MARIE J. STUART, JON DUSSE, DAVID A. CLARK AND RONALD W. WALENGA Divisions of Pediatric Hematology-Oncology and Neonatology, Department of Pediatrics, State University of New York, Upstate Medical Center, Syracuse, New York 13210 Summary An impairment in platelet function is well recognized in the neonate, and includes abnormalities in the release of storage pool In this study, we have investigated the possible role of the pro- adenine nucleotides, and aggregation responses to a variety of aggregatory arachidonic acid (AA) metabolite thromboxane, in stimuli (2, 3, 10). A previous evaluation of exogenous [I4C]AA the impaired function of neonatal platelets. In platelet-rich metabolism in the platelet of the neonate did not suggest that plasma thromboxane production (measured by radioimmunoas- neonatal platelet dysfunction is related to any specific abnor- say of thromboxane B2) was not different between neonates and mality in this pathway (1 3). We observed an increased release of adults when stimulated by thrombin (at 0.1 or 1.0 U/ml) or endogenous AA from neonatal platelet membrane phospholip- collagen (70 pg/ml) although neonatal platelets produced de- ids, and decreased activity of neonatal platelet cyclooxygenase. creased thromboxane (TBXZ) postepinephrine stimulation. In These two effects counteracted each other resulting in similar response to 1 U/ml thrombin, adult and neonatal platelet-rich conversion of prelabeled arachidonic acid to TXBz in adult and plasmas produced mean values of 3.41 + 0.35 (SEM) and 3.11 f 0.49 pmol of TXB2/106 platelets, respectively.
    [Show full text]
  • Carboxylic Acids
    13 Carboxylic Acids The active ingredients in these two nonprescription pain relievers are derivatives of arylpropanoic acids. See Chemical Connections 13A, “From Willow Bark to Aspirin and Beyond.” Inset: A model of (S)-ibuprofen. (Charles D. Winters) KEY QUESTIONS 13.1 What Are Carboxylic Acids? HOW TO 13.2 How Are Carboxylic Acids Named? 13.1 How to Predict the Product of a Fischer 13.3 What Are the Physical Properties of Esterification Carboxylic Acids? 13.2 How to Predict the Product of a B-Decarboxylation 13.4 What Are the Acid–Base Properties of Reaction Carboxylic Acids? 13.5 How Are Carboxyl Groups Reduced? CHEMICAL CONNECTIONS 13.6 What Is Fischer Esterification? 13A From Willow Bark to Aspirin and Beyond 13.7 What Are Acid Chlorides? 13B Esters as Flavoring Agents 13.8 What Is Decarboxylation? 13C Ketone Bodies and Diabetes CARBOXYLIC ACIDS ARE another class of organic compounds containing the carbonyl group. Their occurrence in nature is widespread, and they are important components of foodstuffs such as vinegar, butter, and vegetable oils. The most important chemical property of carboxylic acids is their acidity. Furthermore, carboxylic acids form numerous important derivatives, including es- ters, amides, anhydrides, and acid halides. In this chapter, we study carboxylic acids themselves; in Chapters 14 and 15, we study their derivatives. 457 458 CHAPTER 13 Carboxylic Acids 13.1 What Are Carboxylic Acids? Carboxyl group A J COOH The functional group of a carboxylic acid is a carboxyl group, so named because it is made group. up of a carbonyl group and a hydroxyl group (Section 1.7D).
    [Show full text]
  • Cytokines, Angiogenic, and Antiangiogenic Factors and Bioactive Lipids in Preeclampsia
    Nutrition 31 (2015) 1083–1095 Contents lists available at ScienceDirect Nutrition journal homepage: www.nutritionjrnl.com Review Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia Undurti N. Das M.D., F.A.M.S., F.R.S.C. * UND Life Sciences, Federal Way, WA 98003, USA and Department of Medicine, GVP Hospital and BioScience Research Centre, Campus of Gayatri Vidya Parishad College of Engineering, Visakhapatnam, India article info abstract Article history: Preeclampsia is a low-grade systemic inflammatory condition in which oxidative stress and Received 21 October 2014 endothelial dysfunction occurs. Plasma levels of soluble receptor for vascular endothelial growth Accepted 19 March 2015 factor (VEGFR)-1, also known as sFlt1 (soluble fms-like tyrosine kinase 1), an antiangiogenic factor have been reported to be elevated in preeclampsia. It was reported that pregnant mice deficient in Keywords: catechol-O-methyltransferase (COMT) activity show a preeclampsia-like phenotype due to a Preeclampsia deficiency or absence of 2-methoxyoestradiol (2-ME), a natural metabolite of estradiol that is Lipoxins elevated during the third trimester of normal human pregnancy. Additionally, autoantibodies (AT1- Oxidative stress 2-Methoxyestradiol AAs) that bind and activate the angiotensin II receptor type 1 a (AT1 receptor) also have a role in Polyunsaturated fatty acids preeclampsia. None of these abnormalities are consistently seen in all the patients with pre- Vascular endothelial growth factor eclampsia and some of them are not specific to pregnancy. Preeclampsia could occur due to an Endoglin imbalance between pro- and antiangiogenic factors. VEGF, an angiogenic factor, is necessary for the Soluble fms-like tyrosine kinase 1 transport of polyunsaturated fatty acids (PUFAs) to endothelial cells.
    [Show full text]
  • Otto-Catalog-2019-20.Pdf
    Lab Chemicals & More..... Otto Catalog 2019-20 1 CODE PRODUCT NAME CAS NO. PACKING RATE ` PACKING RATE ` A 1214 ABSCISIC ACID practical grade 10% 14375-45-2 100mg 2007 1gm 13059 A 1215 ABSCISIC ACID for biochemistry 99% 14375-45-2 25mg 1395 100mg 3609 500 mg 17469 A 1217 (7-AMINO CEPHALOSPORANIC ACID) 7-ACA 98% 957-68-6 1gm 2403 5gm 9396 A 1225 ACACIA 9000-01-5 500gm 504 5kg 4392 A 1226 ACACIA spray dried powder 9000-01-5 500gm 684 5kg 6309 A 1227 ACACIA GR 9000-01-5 500gm 828 5kg 7407 A 0855 ACARBOSE, >95% 56180-94-0 1 gm 18099 A 1229 ACENAPHTHENE pract 83-32-9 100gm 306 500gm 1395 5 kg 11907 A 1230 ACENAPHTHENE for synthesis 97% 83-32-9 100gm 450 500gm 1692 A 1231 ACENAPHTHENE GR for HLPC 83-32-9 100gm 1359 500gm 5533 A 1234 ACES BUFFER 99% 7365-82-4 5gm 864 25gm 2385 [N-(2-Acetamido)-2-aminoethane sulfonic acid] 100 gm 8739 A 1233 ACETALDEHYDE 20-30% solution for synthesis 75-07-0 500ml 477 5lt 4095 A 1235 ACETAMIDE for synthesis 99% 60-35-5 500 gm 801 A 1240 ACETAMIDINE CHLORIDE for synthesis 124-42-5 100gm 3159 250gm 7830 A 1242 N-(2-ACETAMIDO) IMINODIACETIC ACID (ADA BUFFER) 26239-55-4 25gm 855 100gm 2592 250 gm 5994 A 1245 ACETANILIDE for synthesis 98.5% 103-84-4 500gm 918 5kg 8289 A 1248 ACETATE BUFFER SOLUTION pH 4.6 - - - - - 500ml 180 5lt 1449 A 1250 ACETIC ACID glacial 99% 64-19-7 500ml 207 5lt 1602 A 1251 ACETIC ACID glacial GR 99%+ 64-19-7 500ml 252 5lt 1908 A 1252 ACETIC ACID GLACIAL GR 99.7% 64-19-7 500ml 315 5lt 1998 A 1253 ACETIC ACID GLACIAL EL 99.9% 64-19-7 500ml 378 5lt 2502 A 1254 ACETIC ACID 99.8% for HPLC 64-19-7
    [Show full text]